AI assistant
Sending…
KIRBY CORP — Director's Dealing 2017
Jan 26, 2017
31065_dirs_2017-01-26_8fc0e037-93df-4929-90f3-ad92d4b64e9a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: KIRBY CORP (KEX)
CIK: 0000056047
Period of Report: 2017-01-16
Reporting Person: O'Neil Christian G. (EVP & COO-Marine Transportatio)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, par value $.10 per share | 28088 | Direct |
| Common Stock, par value $.10 per share | 1645 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $46.74 | 2018-01-31 | Common Stock (550) | Direct | |
| Employee Stock Option (Right to Buy) | $66.72 | 2019-02-06 | Common Stock (4731) | Direct | |
| Employee Stock Option (Right to Buy) | $70.65 | 2020-02-04 | Common Stock (6174) | Direct | |
| Employee Stock Option (Right to Buy) | $93.64 | 2021-02-03 | Common Stock (3861) | Direct | |
| Employee Stock Option (Right to Buy) | $101.46 | 2021-02-25 | Common Stock (237) | Direct | |
| Employee Stock Option (Right to Buy) | $74.99 | 2022-02-02 | Common Stock (5628) | Direct | |
| Employee Stock Option (Right to Buy) | $51.23 | 2023-02-01 | Common Stock (9075) | Direct | |
| Employee Stock Option (Right to Buy) | $64.89 | 2025-05-02 | Common Stock (15500) | Direct |
Footnotes
F1: Option is exercisable 33% after one year, 67% after two years and 100% after three years from date of grant. The date shown is the date the first 33% became or will become exercisable.
More from KIRBY CORP
Major Shareholding Notification
2026
May 11
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 30
Regulatory Filings
2026
Mar 30
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Mar 7
Proxy Solicitation & Information Statement
2026
Mar 6
Proxy Solicitation & Information Statement
2026
Mar 6
Director's Dealing
2026
Feb 26